# active_site_0015: before and after transfer clarification

[All 1,328 cases](../README.md) · [Method](../METHOD.md) · [Summary](../SUMMARY.md) · [Exact reviewer user message](../inputs/active_site_0015.txt)

**Task:** `active_site`  
**Author key, unchanged:** **B** — Position 385 (Glycyl thioester intermediate)

| Round | Reviewer | Key support | Transfer / lookup | Output usability (canonical status) |
|---|---|---|---|---|
| before | GPT-6 Luna | supported | lookup-dependent | usable output (valid_review) |
| before | Qwen3.8-Flash-Next-NVFP4 | supported | lookup-dependent | usable output (valid_review) |
| after | GPT-6 Luna | supported | reasoning-supported | usable output (valid_review) |
| after | Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | usable output (valid_review) |

**Usable output means format-valid review, not reasoning-supported or biologically correct.** A usable output can classify the question as reasoning-supported, lookup-dependent or uncertain. An output error is a problem with the saved model response; it does not count a defective benchmark question or wrong key. Each saved review is retained in full below. Labels from output errors are displayed as saved and excluded from label statistics. The author key and reviewer evidence were visible to reviewers; this is a review of answerability and key support, not a benchmark-solving score.

## Complete original question

```text
[Protein Sequence]
MNLTLDHTTLHRAAKYFMDSGKAASHEAAMNLLQQFGLTIYVGEEIRSSAAHQIALLTIVNVTRRTLLGGVEVIGLPDCDSLTALAPNTGLKEAVMALGGTPVAVARPEWPTALIGSVEDYSNKDTAWRVTWEGWRAGAAPLMIGDRLSEDNSMALAPALAAAVCAGEVFSHYAGDHPMAGRRTAGLSLWQPGADWLDVDESEPELAFLPSNLWIIGLGNLGQAFAWLLALMPYETPQELQLVLQDYDRIAPSNDSTSLLSYKHDTNKMKARVVADWLDKRGFTTFIEERRFGPWTKRHADEPGVALCGVDNALARSALDQAGFPLIVEAGLGGGPQAFRSLGIHTFPSSRTAAEIWAKQVALADTSTEDMPAYQALKKSGIDACGLTQLASRTVGVPFVGLIAACLAMSELLRRLHGGKAFEFIAGSTATLQDIEFGTLHAPPYAHGYTRAMPMGWPTAP

[Multiple Choices]
A. Position 661 (For beta-ketoacyl synthase activity)
B. Position 385 (Glycyl thioester intermediate)
C. Position 10 (Proton donor)
D. Position 700 (For beta-ketoacyl synthase activity)
```

<details>
<summary>Complete original system instructions</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Enzyme Active Site Prediction, which is to identify the key amino acid residues that form the active site of an enzyme. The active site is the specific region on the enzyme where a substrate binds and the chemical reaction is catalyzed. Based on the full protein sequence provided, you must select the option that correctly lists the amino acid residues (by their type and position) that constitute the enzyme's catalytic center.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## Four saved visible reviews

## Before: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The exact sequence matches UniProt entry A0A1I1P074, which annotates position 385 as the active site for a glycyl thioester intermediate. The annotation cites a paper that includes mutagenesis of Cys-385. This supports choice B, though the primary experimental results were not independently reviewed here.

Citations as saved: [C1](#evidence-c1), [C5](#evidence-c5), [C6](#evidence-c6), [H2](#evidence-h2), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence and options reveal that positions 661 and 700 exceed the 461-residue sequence, and position 10 is leucine, making those distractors implausible. But this does not establish which in-range residue is the active site or that it forms a glycyl thioester intermediate.


**Missing item-specific fact**

> That Cys-385 of this particular protein is annotated as the active site involved in a glycyl thioester intermediate.


**Reason**

> The keyed role is a protein-specific functional fact not established by the supplied sequence alone. The supporting annotation and cited mutagenesis evidence are reviewer-only, not information supplied to the evaluated model.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> B is the only plausible listed option: the other positions are out of range or identify leucine as a proton donor. Those eliminations do not independently demonstrate the active-site role.


### Important caveats

- The supporting UniProt annotation is linked to a publication and mutagenesis of Cys-385, but the primary paper was not independently assessed.
- The sequence match establishes applicability of the annotation to the supplied sequence; the exact author source snapshot is unknown.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence and options reveal that positions 661 and 700 exceed the 461-residue sequence, and position 10 is leucine, making those distractors implausible. But this does not establish which in-range residue is the active site or that it forms a glycyl thioester intermediate.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "That Cys-385 of this particular protein is annotated as the active site involved in a glycyl thioester intermediate.",
    "reason": "The keyed role is a protein-specific functional fact not established by the supplied sequence alone. The supporting annotation and cited mutagenesis evidence are reviewer-only, not information supplied to the evaluated model."
  },
  "case_id": "active_site_0015",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C5",
      "C6",
      "H2",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The exact sequence matches UniProt entry A0A1I1P074, which annotates position 385 as the active site for a glycyl thioester intermediate. The annotation cites a paper that includes mutagenesis of Cys-385. This supports choice B, though the primary experimental results were not independently reviewed here."
  },
  "important_caveats": [
    "The supporting UniProt annotation is linked to a publication and mutagenesis of Cys-385, but the primary paper was not independently assessed.",
    "The sequence match establishes applicability of the annotation to the supplied sequence; the exact author source snapshot is unknown."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "B is the only plausible listed option: the other positions are out of range or identify leucine as a proton donor. Those eliminations do not independently demonstrate the active-site role."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "active_site_0015",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The exact sequence matches UniProt entry A0A1I1P074, which annotates position 385 as the active site for a glycyl thioester intermediate. The annotation cites a paper that includes mutagenesis of Cys-385. This supports choice B, though the primary experimental results were not independently reviewed here.",
    "evidence_ids": ["C1", "C5", "C6", "H2", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence and options reveal that positions 661 and 700 exceed the 461-residue sequence, and position 10 is leucine, making those distractors implausible. But this does not establish which in-range residue is the active site or that it forms a glycyl thioester intermediate.",
    "missing_item_specific_fact": "That Cys-385 of this particular protein is annotated as the active site involved in a glycyl thioester intermediate.",
    "reason": "The keyed role is a protein-specific functional fact not established by the supplied sequence alone. The supporting annotation and cited mutagenesis evidence are reviewer-only, not information supplied to the evaluated model."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "B is the only plausible listed option: the other positions are out of range or identify leucine as a proton donor. Those eliminations do not independently demonstrate the active-site role."
  },
  "important_caveats": [
    "The supporting UniProt annotation is linked to a publication and mutagenesis of Cys-385, but the primary paper was not independently assessed.",
    "The sequence match establishes applicability of the annotation to the supplied sequence; the exact author source snapshot is unknown."
  ]
}
```

</details>

## Before: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt entry A0A1I1P074 (Bacterial E1-like protein BilD, EC 6.2.1.-) annotates an Active site at position 385 described as 'Glycyl thioester intermediate' (evidence ECO:0000305, PubMed:39020165). The cited reference (Hoer et al., Nature 631:850-856, 2024) reports 'FUNCTION, PROBABLE ACTIVE SITE, AND MUTAGENESIS OF CYS-385,' providing experimental support via mutagenesis. The sequence SHA-256 matches exactly (461 AA). This is consistent with E1 enzyme biochemistry where a catalytic cysteine forms a thioester intermediate with ubiquitin/ubiquitin-like proteins. Options A (position 661) and D (position 700) are beyond the 461-residue protein length, making them impossible.

Citations as saved: [C1](#evidence-c1), [C4](#evidence-c4), [C5](#evidence-c5), [C6](#evidence-c6), [H1](#evidence-h1), [H2](#evidence-h2), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> General E1 enzyme biochemistry states that E1 (ubiquitin-activating) enzymes use a catalytic cysteine to form a thioester intermediate with the C-terminus of ubiquitin/ubiquitin-like proteins. This mechanistic knowledge eliminates option C ('Proton donor'), which is inconsistent with E1 catalysis. Options A and D are trivially eliminable because positions 661 and 700 exceed the 461-residue protein length. However, positively identifying this specific protein as E1-like from the raw sequence (to invoke E1 mechanism) and pinpointing the exact catalytic cysteine at position 385 require protein-specific annotation knowledge or domain-recognition tooling not derivable from general reasoning alone.


**Missing item-specific fact**

> The specific identity of this protein as a bacterial E1-like protein (BilD) and the exact position of its catalytic cysteine (385) are protein-specific facts. While the mechanistic description in option B is consistent with E1 biochemistry, confirming that this particular sequence is an E1-like enzyme and that Cys-385 is its catalytic residue requires database annotation or structural/biochemical characterization of this specific protein.


**Reason**

> The trivial elimination of out-of-range positions (A, D) and the mechanistic inconsistency of 'proton donor' with E1 catalysis (C) provide some reasoning grounds. However, the positive identification of B requires recognizing this specific protein as E1-like from the raw sequence and knowing that position 385 harbors the catalytic cysteine—both of which are item-specific facts not derivable from general biological reasoning applied to the sequence alone.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Options A and D reference positions (661, 700) that exceed the 461-residue protein length, making them physically impossible. Option C ('Proton donor') is mechanistically inconsistent with E1 enzyme catalysis. Only option B provides both a valid position within the protein and a mechanistically correct description for an E1-like enzyme. No ambiguity among defensible choices.


### Important caveats

- Options A and D are trivially eliminable by noting positions 661 and 700 exceed the 461-residue sequence length, reducing effective difficulty.
- The UniProt annotation evidence code ECO:0000305 indicates curator inference from the PubMed reference, but the underlying reference includes mutagenesis of Cys-385 (experimental support).
- The protein was only integrated into Swiss-Prot in April 2025; the author's source snapshot timing is unknown but the sequence has been unchanged since 2017.
- The reviewer-only evidence was absent from the evaluated model's input; the model must work from the raw sequence and options alone.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "General E1 enzyme biochemistry states that E1 (ubiquitin-activating) enzymes use a catalytic cysteine to form a thioester intermediate with the C-terminus of ubiquitin/ubiquitin-like proteins. This mechanistic knowledge eliminates option C ('Proton donor'), which is inconsistent with E1 catalysis. Options A and D are trivially eliminable because positions 661 and 700 exceed the 461-residue protein length. However, positively identifying this specific protein as E1-like from the raw sequence (to invoke E1 mechanism) and pinpointing the exact catalytic cysteine at position 385 require protein-specific annotation knowledge or domain-recognition tooling not derivable from general reasoning alone.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The specific identity of this protein as a bacterial E1-like protein (BilD) and the exact position of its catalytic cysteine (385) are protein-specific facts. While the mechanistic description in option B is consistent with E1 biochemistry, confirming that this particular sequence is an E1-like enzyme and that Cys-385 is its catalytic residue requires database annotation or structural/biochemical characterization of this specific protein.",
    "reason": "The trivial elimination of out-of-range positions (A, D) and the mechanistic inconsistency of 'proton donor' with E1 catalysis (C) provide some reasoning grounds. However, the positive identification of B requires recognizing this specific protein as E1-like from the raw sequence and knowing that position 385 harbors the catalytic cysteine—both of which are item-specific facts not derivable from general biological reasoning applied to the sequence alone."
  },
  "case_id": "active_site_0015",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C4",
      "C5",
      "C6",
      "H1",
      "H2",
      "H3"
    ],
    "judgment": "supported",
    "reason": "UniProt entry A0A1I1P074 (Bacterial E1-like protein BilD, EC 6.2.1.-) annotates an Active site at position 385 described as 'Glycyl thioester intermediate' (evidence ECO:0000305, PubMed:39020165). The cited reference (Hoer et al., Nature 631:850-856, 2024) reports 'FUNCTION, PROBABLE ACTIVE SITE, AND MUTAGENESIS OF CYS-385,' providing experimental support via mutagenesis. The sequence SHA-256 matches exactly (461 AA). This is consistent with E1 enzyme biochemistry where a catalytic cysteine forms a thioester intermediate with ubiquitin/ubiquitin-like proteins. Options A (position 661) and D (position 700) are beyond the 461-residue protein length, making them impossible."
  },
  "important_caveats": [
    "Options A and D are trivially eliminable by noting positions 661 and 700 exceed the 461-residue sequence length, reducing effective difficulty.",
    "The UniProt annotation evidence code ECO:0000305 indicates curator inference from the PubMed reference, but the underlying reference includes mutagenesis of Cys-385 (experimental support).",
    "The protein was only integrated into Swiss-Prot in April 2025; the author's source snapshot timing is unknown but the sequence has been unchanged since 2017.",
    "The reviewer-only evidence was absent from the evaluated model's input; the model must work from the raw sequence and options alone."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options A and D reference positions (661, 700) that exceed the 461-residue protein length, making them physically impossible. Option C ('Proton donor') is mechanistically inconsistent with E1 enzyme catalysis. Only option B provides both a valid position within the protein and a mechanistically correct description for an E1-like enzyme. No ambiguity among defensible choices."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "active_site_0015",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt entry A0A1I1P074 (Bacterial E1-like protein BilD, EC 6.2.1.-) annotates an Active site at position 385 described as 'Glycyl thioester intermediate' (evidence ECO:0000305, PubMed:39020165). The cited reference (Hoer et al., Nature 631:850-856, 2024) reports 'FUNCTION, PROBABLE ACTIVE SITE, AND MUTAGENESIS OF CYS-385,' providing experimental support via mutagenesis. The sequence SHA-256 matches exactly (461 AA). This is consistent with E1 enzyme biochemistry where a catalytic cysteine forms a thioester intermediate with ubiquitin/ubiquitin-like proteins. Options A (position 661) and D (position 700) are beyond the 461-residue protein length, making them impossible.",
    "evidence_ids": ["C1", "C4", "C5", "C6", "H1", "H2", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "General E1 enzyme biochemistry states that E1 (ubiquitin-activating) enzymes use a catalytic cysteine to form a thioester intermediate with the C-terminus of ubiquitin/ubiquitin-like proteins. This mechanistic knowledge eliminates option C ('Proton donor'), which is inconsistent with E1 catalysis. Options A and D are trivially eliminable because positions 661 and 700 exceed the 461-residue protein length. However, positively identifying this specific protein as E1-like from the raw sequence (to invoke E1 mechanism) and pinpointing the exact catalytic cysteine at position 385 require protein-specific annotation knowledge or domain-recognition tooling not derivable from general reasoning alone.",
    "missing_item_specific_fact": "The specific identity of this protein as a bacterial E1-like protein (BilD) and the exact position of its catalytic cysteine (385) are protein-specific facts. While the mechanistic description in option B is consistent with E1 biochemistry, confirming that this particular sequence is an E1-like enzyme and that Cys-385 is its catalytic residue requires database annotation or structural/biochemical characterization of this specific protein.",
    "reason": "The trivial elimination of out-of-range positions (A, D) and the mechanistic inconsistency of 'proton donor' with E1 catalysis (C) provide some reasoning grounds. However, the positive identification of B requires recognizing this specific protein as E1-like from the raw sequence and knowing that position 385 harbors the catalytic cysteine—both of which are item-specific facts not derivable from general biological reasoning applied to the sequence alone."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options A and D reference positions (661, 700) that exceed the 461-residue protein length, making them physically impossible. Option C ('Proton donor') is mechanistically inconsistent with E1 enzyme catalysis. Only option B provides both a valid position within the protein and a mechanistically correct description for an E1-like enzyme. No ambiguity among defensible choices."
  },
  "important_caveats": [
    "Options A and D are trivially eliminable by noting positions 661 and 700 exceed the 461-residue sequence length, reducing effective difficulty.",
    "The UniProt annotation evidence code ECO:0000305 indicates curator inference from the PubMed reference, but the underlying reference includes mutagenesis of Cys-385 (experimental support).",
    "The protein was only integrated into Swiss-Prot in April 2025; the author's source snapshot timing is unknown but the sequence has been unchanged since 2017.",
    "The reviewer-only evidence was absent from the evaluated model's input; the model must work from the raw sequence and options alone."
  ]
}
```

</details>

## After: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The matched sequence's position 385 is annotated as the active-site residue forming a glycyl thioester intermediate. The annotation cites a publication that includes mutagenesis of Cys-385, supporting choice B, though the supplied database annotation is not itself primary experimental data.

Citations as saved: [C5](#evidence-c5), [C6](#evidence-c6), [H3](#evidence-h3).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> Position 385 is within the 461-residue sequence and is a cysteine. A transferable inference from E1-like enzyme chemistry is that a catalytic cysteine can form a thioester with a substrate's terminal glycine; this matches option B. Positions 661 and 700 are outside the sequence, while the stated glycyl-thioester role fits the cysteine better than the proton-donor role offered at position 10.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> The sequence and answer choices permit a meaningful family/mechanism-level inference without needing the exact protein's database record. This supports B probabilistically; the original input alone does not independently prove the protein family or catalytic function.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The two beta-ketoacyl synthase choices are outside the supplied sequence, and the glycyl-thioester description gives a distinct, biologically coherent match for the cysteine at position 385.


### Important caveats

- The source annotation is literature-linked and cites mutagenesis, but the excerpts do not provide the underlying experimental results.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "Position 385 is within the 461-residue sequence and is a cysteine. A transferable inference from E1-like enzyme chemistry is that a catalytic cysteine can form a thioester with a substrate's terminal glycine; this matches option B. Positions 661 and 700 are outside the sequence, while the stated glycyl-thioester role fits the cysteine better than the proton-donor role offered at position 10.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "The sequence and answer choices permit a meaningful family/mechanism-level inference without needing the exact protein's database record. This supports B probabilistically; the original input alone does not independently prove the protein family or catalytic function."
  },
  "case_id": "active_site_0015",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "C6",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The matched sequence's position 385 is annotated as the active-site residue forming a glycyl thioester intermediate. The annotation cites a publication that includes mutagenesis of Cys-385, supporting choice B, though the supplied database annotation is not itself primary experimental data."
  },
  "important_caveats": [
    "The source annotation is literature-linked and cites mutagenesis, but the excerpts do not provide the underlying experimental results."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The two beta-ketoacyl synthase choices are outside the supplied sequence, and the glycyl-thioester description gives a distinct, biologically coherent match for the cysteine at position 385."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "active_site_0015",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The matched sequence's position 385 is annotated as the active-site residue forming a glycyl thioester intermediate. The annotation cites a publication that includes mutagenesis of Cys-385, supporting choice B, though the supplied database annotation is not itself primary experimental data.",
    "evidence_ids": ["C5", "C6", "H3"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "Position 385 is within the 461-residue sequence and is a cysteine. A transferable inference from E1-like enzyme chemistry is that a catalytic cysteine can form a thioester with a substrate's terminal glycine; this matches option B. Positions 661 and 700 are outside the sequence, while the stated glycyl-thioester role fits the cysteine better than the proton-donor role offered at position 10.",
    "missing_item_specific_fact": "",
    "reason": "The sequence and answer choices permit a meaningful family/mechanism-level inference without needing the exact protein's database record. This supports B probabilistically; the original input alone does not independently prove the protein family or catalytic function."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The two beta-ketoacyl synthase choices are outside the supplied sequence, and the glycyl-thioester description gives a distinct, biologically coherent match for the cysteine at position 385."
  },
  "important_caveats": [
    "The source annotation is literature-linked and cites mutagenesis, but the excerpts do not provide the underlying experimental results."
  ]
}
```

</details>

## After: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt annotates ACT_SITE at position 385 with 'Glycyl thioester intermediate' (ECO:0000305, inferred by curator based on PubMed:39020165). The cited Nature 2024 reference (Hoer et al.) reports 'PROBABLE ACTIVE SITE' and 'MUTAGENESIS OF CYS-385,' providing experimental mutagenesis support for Cys-385 as the catalytic residue. The evidence code is ECO:0000305 (curator inference) rather than direct experimental proof, but the underlying mutagenesis data in the primary paper substantiates the annotation. The description 'Glycyl thioester intermediate' is mechanistically consistent with E1 enzyme catalysis.

Citations as saved: [C5](#evidence-c5), [C6](#evidence-c6), [H3](#evidence-h3), [H2](#evidence-h2).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> Three independent lines of transferable reasoning distinguish B from the other options: (1) The protein is 461 amino acids long, so positions 661 (A) and 700 (D) are physically impossible and can be eliminated by simple arithmetic. (2) Position 10 is Leucine (M-N-L-T-L-D-H-T-T-L), which is a hydrophobic, non-catalytic residue incapable of acting as a proton donor or forming a thioester, eliminating C. (3) The protein sequence exhibits hallmarks of the E1 enzyme superfamily (ubiquitin-activating enzymes): a conserved 'GLGG' nucleotide-binding motif near the middle of the sequence, overall domain architecture consistent with adenylation and thioester-forming domains, and the 'ACGLT' motif near position 385 containing a cysteine. Across all known E1 enzymes (human UBA1, yeast Uba1, bacterial E1-like proteins), the universal catalytic mechanism involves an active-site cysteine forming a thioester bond with the C-terminal glycine of the substrate (ubiquitin or ubiquitin-like protein). The descriptor 'Glycyl thioester intermediate' in option B is the mechanistic signature of E1 catalysis. A model recognizing E1 family features and applying the conserved thioester-intermediate mechanism can identify position 385 as the catalytic cysteine without knowing this protein's specific database record.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> The question is answerable through: (a) elimination of positions exceeding the 461-aa sequence length (A, D), (b) recognition that position 10 is Leucine and cannot be a proton donor (C), and (c) E1 enzyme family knowledge that the catalytic mechanism universally involves a Cys forming a glycyl thioester intermediate, pointing to position 385. The 'Glycyl thioester intermediate' label in option B is a mechanistic descriptor shared across the entire E1 superfamily, making it transferable knowledge rather than a protein-specific annotation lookup.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Options A and D reference positions beyond the 461-residue protein and are physically impossible. Option C assigns a proton-donor role to Leucine at position 10, which is biochemically implausible. Only option B is mechanistically and structurally consistent with the sequence and E1 enzyme biology.


### Important caveats

- The UniProt annotation uses ECO:0000305 (inferred by curator), and the primary reference qualifies the site as 'PROBABLE ACTIVE SITE' with mutagenesis of Cys-385 as supporting evidence. This is not a direct crystallographic or kinetic determination but is backed by functional mutagenesis data.
- The protein identity (BilD, Collimonas sp. OK412) and its E1-like classification were not provided in the original model input; the model must infer E1 family membership from sequence features alone.
- Positions 661 and 700 being impossible is a trivial elimination based on sequence length, which makes the question somewhat easier than a typical active-site prediction task.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "Three independent lines of transferable reasoning distinguish B from the other options: (1) The protein is 461 amino acids long, so positions 661 (A) and 700 (D) are physically impossible and can be eliminated by simple arithmetic. (2) Position 10 is Leucine (M-N-L-T-L-D-H-T-T-L), which is a hydrophobic, non-catalytic residue incapable of acting as a proton donor or forming a thioester, eliminating C. (3) The protein sequence exhibits hallmarks of the E1 enzyme superfamily (ubiquitin-activating enzymes): a conserved 'GLGG' nucleotide-binding motif near the middle of the sequence, overall domain architecture consistent with adenylation and thioester-forming domains, and the 'ACGLT' motif near position 385 containing a cysteine. Across all known E1 enzymes (human UBA1, yeast Uba1, bacterial E1-like proteins), the universal catalytic mechanism involves an active-site cysteine forming a thioester bond with the C-terminal glycine of the substrate (ubiquitin or ubiquitin-like protein). The descriptor 'Glycyl thioester intermediate' in option B is the mechanistic signature of E1 catalysis. A model recognizing E1 family features and applying the conserved thioester-intermediate mechanism can identify position 385 as the catalytic cysteine without knowing this protein's specific database record.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "The question is answerable through: (a) elimination of positions exceeding the 461-aa sequence length (A, D), (b) recognition that position 10 is Leucine and cannot be a proton donor (C), and (c) E1 enzyme family knowledge that the catalytic mechanism universally involves a Cys forming a glycyl thioester intermediate, pointing to position 385. The 'Glycyl thioester intermediate' label in option B is a mechanistic descriptor shared across the entire E1 superfamily, making it transferable knowledge rather than a protein-specific annotation lookup."
  },
  "case_id": "active_site_0015",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "C6",
      "H3",
      "H2"
    ],
    "judgment": "supported",
    "reason": "UniProt annotates ACT_SITE at position 385 with 'Glycyl thioester intermediate' (ECO:0000305, inferred by curator based on PubMed:39020165). The cited Nature 2024 reference (Hoer et al.) reports 'PROBABLE ACTIVE SITE' and 'MUTAGENESIS OF CYS-385,' providing experimental mutagenesis support for Cys-385 as the catalytic residue. The evidence code is ECO:0000305 (curator inference) rather than direct experimental proof, but the underlying mutagenesis data in the primary paper substantiates the annotation. The description 'Glycyl thioester intermediate' is mechanistically consistent with E1 enzyme catalysis."
  },
  "important_caveats": [
    "The UniProt annotation uses ECO:0000305 (inferred by curator), and the primary reference qualifies the site as 'PROBABLE ACTIVE SITE' with mutagenesis of Cys-385 as supporting evidence. This is not a direct crystallographic or kinetic determination but is backed by functional mutagenesis data.",
    "The protein identity (BilD, Collimonas sp. OK412) and its E1-like classification were not provided in the original model input; the model must infer E1 family membership from sequence features alone.",
    "Positions 661 and 700 being impossible is a trivial elimination based on sequence length, which makes the question somewhat easier than a typical active-site prediction task."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options A and D reference positions beyond the 461-residue protein and are physically impossible. Option C assigns a proton-donor role to Leucine at position 10, which is biochemically implausible. Only option B is mechanistically and structurally consistent with the sequence and E1 enzyme biology."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "active_site_0015",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt annotates ACT_SITE at position 385 with 'Glycyl thioester intermediate' (ECO:0000305, inferred by curator based on PubMed:39020165). The cited Nature 2024 reference (Hoer et al.) reports 'PROBABLE ACTIVE SITE' and 'MUTAGENESIS OF CYS-385,' providing experimental mutagenesis support for Cys-385 as the catalytic residue. The evidence code is ECO:0000305 (curator inference) rather than direct experimental proof, but the underlying mutagenesis data in the primary paper substantiates the annotation. The description 'Glycyl thioester intermediate' is mechanistically consistent with E1 enzyme catalysis.",
    "evidence_ids": ["C5", "C6", "H3", "H2"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "Three independent lines of transferable reasoning distinguish B from the other options: (1) The protein is 461 amino acids long, so positions 661 (A) and 700 (D) are physically impossible and can be eliminated by simple arithmetic. (2) Position 10 is Leucine (M-N-L-T-L-D-H-T-T-L), which is a hydrophobic, non-catalytic residue incapable of acting as a proton donor or forming a thioester, eliminating C. (3) The protein sequence exhibits hallmarks of the E1 enzyme superfamily (ubiquitin-activating enzymes): a conserved 'GLGG' nucleotide-binding motif near the middle of the sequence, overall domain architecture consistent with adenylation and thioester-forming domains, and the 'ACGLT' motif near position 385 containing a cysteine. Across all known E1 enzymes (human UBA1, yeast Uba1, bacterial E1-like proteins), the universal catalytic mechanism involves an active-site cysteine forming a thioester bond with the C-terminal glycine of the substrate (ubiquitin or ubiquitin-like protein). The descriptor 'Glycyl thioester intermediate' in option B is the mechanistic signature of E1 catalysis. A model recognizing E1 family features and applying the conserved thioester-intermediate mechanism can identify position 385 as the catalytic cysteine without knowing this protein's specific database record.",
    "missing_item_specific_fact": "",
    "reason": "The question is answerable through: (a) elimination of positions exceeding the 461-aa sequence length (A, D), (b) recognition that position 10 is Leucine and cannot be a proton donor (C), and (c) E1 enzyme family knowledge that the catalytic mechanism universally involves a Cys forming a glycyl thioester intermediate, pointing to position 385. The 'Glycyl thioester intermediate' label in option B is a mechanistic descriptor shared across the entire E1 superfamily, making it transferable knowledge rather than a protein-specific annotation lookup."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options A and D reference positions beyond the 461-residue protein and are physically impossible. Option C assigns a proton-donor role to Leucine at position 10, which is biochemically implausible. Only option B is mechanistically and structurally consistent with the sequence and E1 enzyme biology."
  },
  "important_caveats": [
    "The UniProt annotation uses ECO:0000305 (inferred by curator), and the primary reference qualifies the site as 'PROBABLE ACTIVE SITE' with mutagenesis of Cys-385 as supporting evidence. This is not a direct crystallographic or kinetic determination but is backed by functional mutagenesis data.",
    "The protein identity (BilD, Collimonas sp. OK412) and its E1-like classification were not provided in the original model input; the model must infer E1 family membership from sequence features alone.",
    "Positions 661 and 700 being impossible is a trivial elimination based on sequence length, which makes the question somewhat easier than a typical active-site prediction task."
  ]
}
```

</details>

## Existing project source checks of the old Luna review only

These unchanged notes concern the earlier Luna claims. They do not validate either new review or the old Qwen review. No new scientific adjudication was performed.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Complete reviewer-only evidence and qualifications

All excerpts supplied in the original and revised reviewer user message follow. This material was not available to the original evaluated model. Accession identity came from dataset image-path metadata. Source support and transferable discrimination are separate judgments.

**Applicability metadata, unchanged:**

```json
{
  "requested_accession": "A0A1I1P074",
  "identity_origin": "reviewer-only accession inferred mechanically from original dataset image-path metadata; this accession/metadata was absent from evaluated model input",
  "benchmark_sequence_sha256": "41932a11ef3e7a2f44ccd75bad17dee7b891dfe4dd486698c3c078f6b2c6f62e",
  "benchmark_sequence_length": 461,
  "current_status": "retrieved",
  "current_sequence_comparison": "matched",
  "current_entry_audit": {
    "entryVersion": 15,
    "firstPublicDate": "2025-04-09",
    "lastAnnotationUpdateDate": "2026-09-02",
    "lastSequenceUpdateDate": "2017-11-22",
    "sequenceVersion": 1
  },
  "current_uniprot_release": "2026_03",
  "current_record_sha256": "85e7a104b9ec3fed02e35ea4232cf86a383df56f7435a81173e8fa183bf247be",
  "current_source_sequence_sha256": "41932a11ef3e7a2f44ccd75bad17dee7b891dfe4dd486698c3c078f6b2c6f62e",
  "current_source_sequence_length": 461,
  "historical_status": "retrieved",
  "historical_cutoff_date": "2026-05-07",
  "historical_sequence_comparison": "matched",
  "selected_historical_entry_version": 13,
  "selected_historical_version": {
    "accession": "A0A1I1P074",
    "database": "Swiss-Prot",
    "entryVersion": 13,
    "firstRelease": "2026_01/2026_01",
    "firstReleaseDate": "28-Jan-2026",
    "lastRelease": "2026_01/2026_01",
    "lastReleaseDate": "28-Jan-2026",
    "name": "BILD_COLS4",
    "sequenceVersion": 1
  },
  "selected_historical_record_sha256": "a37af1ad780f0f67b0b403cc351978c7e209c2d02ee53894ad0fc5e2c09bea6a",
  "selected_historical_source_sequence_sha256": "41932a11ef3e7a2f44ccd75bad17dee7b891dfe4dd486698c3c078f6b2c6f62e",
  "selected_historical_source_sequence_length": 461,
  "latest_at_cutoff_sequence_comparison": "matched",
  "historical_sequence_versions_checked": [
    {
      "entry_version": 13,
      "exact_sequence_comparison": "matched",
      "sequence_version": 1
    }
  ],
  "actual_author_source_snapshot": "unknown",
  "numbering": "Canonical entry coordinates; construct or isoform numbering is not assumed."
}
```

**Qualifications, unchanged:**

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A1I1P074.json)

```json
{
  "evidence_id": "C1",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A1I1P074.json",
  "source_sha256": "85e7a104b9ec3fed02e35ea4232cf86a383df56f7435a81173e8fa183bf247be",
  "retrieved_utc": "2026-11-02T04:24:37.902008+00:00",
  "json_pointer": "/primaryAccession",
  "excerpt": "\"A0A1I1P074\"",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C2

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A1I1P074.json)

```json
{
  "evidence_id": "C2",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A1I1P074.json",
  "source_sha256": "85e7a104b9ec3fed02e35ea4232cf86a383df56f7435a81173e8fa183bf247be",
  "retrieved_utc": "2026-11-02T04:24:37.902008+00:00",
  "json_pointer": "/entryAudit",
  "excerpt": "{\"entryVersion\":15,\"firstPublicDate\":\"2025-04-09\",\"lastAnnotationUpdateDate\":\"2026-09-02\",\"lastSequenceUpdateDate\":\"2017-11-22\",\"sequenceVersion\":1}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C3

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A1I1P074.json)

```json
{
  "evidence_id": "C3",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A1I1P074.json",
  "source_sha256": "85e7a104b9ec3fed02e35ea4232cf86a383df56f7435a81173e8fa183bf247be",
  "retrieved_utc": "2026-11-02T04:24:37.902008+00:00",
  "json_pointer": "/organism",
  "excerpt": "{\"lineage\":[\"Bacteria\",\"Pseudomonadati\",\"Pseudomonadota\",\"Betaproteobacteria\",\"Burkholderiales\",\"Oxalobacteraceae\",\"Collimonas\"],\"scientificName\":\"Collimonas sp. (strain OK412)\",\"taxonId\":1801619}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A1I1P074.json)

```json
{
  "evidence_id": "C4",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A1I1P074.json",
  "source_sha256": "85e7a104b9ec3fed02e35ea4232cf86a383df56f7435a81173e8fa183bf247be",
  "retrieved_utc": "2026-11-02T04:24:37.902008+00:00",
  "json_pointer": "/proteinDescription",
  "excerpt": "{\"alternativeNames\":[{\"fullName\":{\"value\":\"E1 ubiquitin-conjugating enzyme BilD\"}}],\"recommendedName\":{\"ecNumbers\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000305\",\"id\":\"39020165\",\"source\":\"PubMed\"}],\"value\":\"6.2.1.-\"}],\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"39020165\",\"source\":\"PubMed\"}],\"value\":\"Bacterial E1-like protein BilD\"}}}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A1I1P074.json)

```json
{
  "evidence_id": "C5",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A1I1P074.json",
  "source_sha256": "85e7a104b9ec3fed02e35ea4232cf86a383df56f7435a81173e8fa183bf247be",
  "retrieved_utc": "2026-11-02T04:24:37.902008+00:00",
  "json_pointer": "/features/1",
  "excerpt": "{\"description\":\"Glycyl thioester intermediate\",\"evidences\":[{\"evidenceCode\":\"ECO:0000305\",\"id\":\"39020165\",\"source\":\"PubMed\"}],\"location\":{\"end\":{\"modifier\":\"EXACT\",\"value\":385},\"start\":{\"modifier\":\"EXACT\",\"value\":385}},\"type\":\"Active site\"}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A1I1P074.json)

```json
{
  "evidence_id": "C6",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/A0A1I1P074.json",
  "source_sha256": "85e7a104b9ec3fed02e35ea4232cf86a383df56f7435a81173e8fa183bf247be",
  "retrieved_utc": "2026-11-02T04:24:37.902008+00:00",
  "json_pointer": "/references/1",
  "excerpt": "{\"citation\":{\"authors\":[\"Hoer J.\",\"Wolf S.G.\",\"Sorek R.\"],\"citationCrossReferences\":[{\"database\":\"PubMed\",\"id\":\"39020165\"},{\"database\":\"DOI\",\"id\":\"10.1038/s41586-024-07616-5\"}],\"citationType\":\"journal article\",\"firstPage\":\"850\",\"id\":\"39020165\",\"journal\":\"Nature\",\"lastPage\":\"856\",\"publicationDate\":\"2024\",\"title\":\"Bacteria conjugate ubiquitin-like proteins to interfere with phage assembly.\",\"volume\":\"631\"},\"referenceNumber\":2,\"referencePositions\":[\"FUNCTION\",\"PROBABLE ACTIVE SITE\",\"MUTAGENESIS OF CYS-385\"]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A1I1P074?format=txt&versions=13)

```json
{
  "evidence_id": "H1",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0A1I1P074?format=txt&versions=13",
  "source_sha256": "a37af1ad780f0f67b0b403cc351978c7e209c2d02ee53894ad0fc5e2c09bea6a",
  "retrieved_utc": "2026-11-02T04:24:41.131133+00:00",
  "source_locator": "lines 1-14",
  "excerpt": "ID   BILD_COLS4              Reviewed;         461 AA.\nAC   A0A1I1P074;\nDT   09-APR-2025, integrated into UniProtKB/Swiss-Prot.\nDT   22-NOV-2017, sequence version 1.\nDT   28-JAN-2026, entry version 13.\nDE   RecName: Full=Bacterial E1-like protein BilD {ECO:0000303|PubMed:39020165};\nDE            EC=6.2.1.- {ECO:0000305|PubMed:39020165};\nDE   AltName: Full=E1 ubiquitin-conjugating enzyme BilD;\nGN   Name=bilD {ECO:0000303|PubMed:39020165};\nGN   ORFNames=SAMN04515619_11955 {ECO:0000312|EMBL:SFD01128.1};\nOS   Collimonas sp. (strain OK412).\nOC   Bacteria; Pseudomonadati; Pseudomonadota; Betaproteobacteria;\nOC   Burkholderiales; Oxalobacteraceae; Collimonas.\nOX   NCBI_TaxID=1801619;\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 13,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A1I1P074?format=txt&versions=13)

```json
{
  "evidence_id": "H2",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0A1I1P074?format=txt&versions=13",
  "source_sha256": "a37af1ad780f0f67b0b403cc351978c7e209c2d02ee53894ad0fc5e2c09bea6a",
  "retrieved_utc": "2026-11-02T04:24:41.131133+00:00",
  "source_locator": "lines 20-26",
  "excerpt": "RN   [2]\nRP   FUNCTION, PROBABLE ACTIVE SITE, AND MUTAGENESIS OF CYS-385.\nRX   PubMed=39020165; DOI=10.1038/s41586-024-07616-5;\nRA   Hoer J., Wolf S.G., Sorek R.;\nRT   \"Bacteria conjugate ubiquitin-like proteins to interfere with phage\nRT   assembly.\";\nRL   Nature 631:850-856(2024).\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 13,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A1I1P074?format=txt&versions=13)

```json
{
  "evidence_id": "H3",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/A0A1I1P074?format=txt&versions=13",
  "source_sha256": "a37af1ad780f0f67b0b403cc351978c7e209c2d02ee53894ad0fc5e2c09bea6a",
  "retrieved_utc": "2026-11-02T04:24:41.131133+00:00",
  "source_locator": "lines 73-75",
  "excerpt": "FT   ACT_SITE        385\nFT                   /note=\"Glycyl thioester intermediate\"\nFT                   /evidence=\"ECO:0000305|PubMed:39020165\"\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 13,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/active_site.json), zero-based source row 15. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). [Source credits](../THIRD_PARTY_NOTICES.md).
